Re merger :CCE's main problem for US approval has been finding suitable patients for treatment and desperately needs this market.The company is suffering from falling revenues.VSG was going forward at an excellent rate and has an off the shelf,ready to go,volume product with distibutors in place.In my view the synergy between the two is not a very compelling reason to merge.Reducing overheads is one thing but without revenue these are only one off savings.The 5/7 share arrangement is useless in this environment and the merged entity will still be worth the sum of the parts only as determined bt thr market.All comments welcome.
Cheers
VSG
visiomed group limited
